Related Experiment Video

Updated: Jul 20, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

[Prophylaxis and treatment for invasive fungal infections in solid organ transplant recipients]

Kotaro Mitsutake1

  • 1Infection Control Unit, Department of Clinical Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology
|August 31, 2006
PubMed

Insights

Invasive fungal infections pose a high mortality risk in solid organ transplant recipients. Antifungal prophylaxis is crucial for high-risk patients, though its use remains debated.

Area of Science:

  • Mycology
  • Transplantation Medicine
  • Infectious Diseases

Context:

  • Solid organ transplantation is increasing in Japan.
  • Invasive fungal infections (IFIs) are less common than bacterial/viral infections but have higher mortality.
  • Successful treatment of IFIs, particularly invasive aspergillosis, is challenging post-diagnosis.

Purpose:

  • To highlight the critical need for identifying high-risk patients in solid organ transplant recipients.
  • To emphasize the importance of antifungal prophylaxis in preventing IFIs.
  • To address the ongoing controversy surrounding antifungal prophylaxis in this patient population.

Summary:

  • Invasive fungal infections (IFIs) present a significant mortality risk in solid organ transplant (SOT) recipients, despite lower incidence compared to bacterial and viral infections.
  • Empiric and pre-emptive antifungal therapies are vital due to treatment difficulties after diagnosis, especially for invasive aspergillosis.
  • Identifying high-risk patients and implementing antifungal prophylaxis are essential for improving outcomes, though its application in SOT recipients remains a subject of debate.

Impact:

  • Improved patient outcomes through targeted antifungal prophylaxis strategies.
  • Potential shift in clinical practice regarding antifungal prophylaxis in solid organ transplant recipients.
  • Guidance for the development and application of new antifungal agents for prevention and treatment.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...